The expirience of IDEAL by E. Z. Burnevich

Subjects: Get full text

The safety, tolerability, pharmacokinetics, and pharmacodynamics of nebulized pegylated interferon α-2b in healthy adults: a randomized phase 1 trial by Wenqi Huang, Yanneng Kang, Yajun Zhao, Jiao Yang, Changjuan Dai, Weibing Wu, Jinchao Xu, Wen Jin, Xiaolu Wu, Qing Zhou

Subjects: “…Pegylated interferon α-2b…”
Get full text

Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot study by Li-Jun Chang, Chun-Qiu Hao, Gui-Rong Rao, Lin-Li Xu, Jing Li, Yan Cheng, Li-Jun Zheng, Cun-Wen Wu, Han-Xian Chen, Ze-Ren Chen, Jian-Qi Lian, Shi-Hong Wu, Li-Min Luo, Wei-Lu Zhang, Ye Zhang

Subjects: Get full text

Success of early antiviral monotherapy with pegylated interferon α-2a for posttransplantation fibrosing cholestatic hepatitis C (a clinical case) by A. V. Chzhao, O. I. Andreitseva, V. E. Syutkin, A. O. Chugunov, K. R. Dzhagrayev, A. A. Saliyenko, I. V. Aleksandrova, V. V. Artamonov, E. A. Soldatov, L. V. Donova, I. E. Galankina, L. N. Zimina

Subjects: Get full text

Adding pegylated interferon-α to nucleos(t)ide analogs improves HBsAg clearance in chronic hepatitis B with low-level viremia by Lilin Wang, Junfeng Lu, Dan Liu, Shan Ren, Xinyue Chen, Zhongjie Hu, Sujun Zheng

Subjects: Get full text

PREVALENCE OF SIDE EFFECTS OF INTERFERON THERAPY IN CHILDREN WITH CHRONIC VIRAL HEPATITIS C by T. A. Skvortsova, G. V. Volynets, A. S. Poyapov, E. L. Semikina

Subjects: Get full text